Stellus Capital Investment (SCM) Misses Q3 EPS by 6c

Stellus Capital Investment (NYSE: SCM) reported Q3 EPS of $0.40, $0.06 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $26.5 million versus the consensus estimate of $27.84 million.

For earnings history and earnings-related data on Stellus Capital Investment (SCM) click here.

You May Also Be Interested In

• Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
• Roivant halts IMVT-1402 development in cutaneous lupus after trial miss
• H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)